OnKure Therapeutics, Inc. (OKUR) Return on equity
OnKure Therapeutics, Inc. (OKUR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-50.7%FY2024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -50.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice